India Infoline News Service | 15:03 IST, Jan 22,2021
On Nifty Pharma, 3 scrips advanced and 7 scrips declined.
India Infoline News Service | 14:06 IST, Jan 22,2021
Heavyweight TCS was in the fast lane followed by substantial gains added by Infosys.
Resolutions in NCLT accounts, lower residual stressed assets and enhanced income recognition and provision write-backs through to ...
Buy Reco. Price: 286
Revival in retail mortgages and corporate lending business, are likely to drive income for the core mortgage business. The core ...
Buy Reco. Price: 2,125
Displaying Events for 24th Dec - 24th Jan 2021